Back

Constitutive immune surveillance of nasal mucosa by three neutrophil subsets with distinct origin, phenotype, and function

Gonzalez, R. J.; Hanc, P.; Alvarez, D.; Kazer, S. W.; Messou, M.-A.; Mazo, I. B.; Matysiak Match, C.; Garg, R.; Helble, J. D.; Pallis, P.; Ende, R.; Basset, A.; Malley, R.; Derre, I.; Starnbach, M. N.; von Andrian, U. H.

2024-03-12 immunology
10.1101/2024.03.06.583781 bioRxiv
Show abstract

The nasal mucosa (NM) has several critical functions, including as a chemosensory organ, as a filter and conditioning surface of inhaled air for the lower airways, and as a first line of defense against airborne infections. Owing to its constant exposure to ever-changing environments, the NM is arguably the most frequently infected tissue in mammals. Consequently, vertebrates harbor an intricate network of subepithelial immune cells that are dispersed throughout the NM. However, the origin, composition, and function of nasal immune cells and their pathophysiological role are poorly understood. Here, we show that murine steady-state NM harbors a prominent population of extravascular neutrophils (EVN) that are abundant in both conventional and germ-free mice, suggesting that their presence is not driven by microbial stimuli. Nasal EVN can be subdivided into three phenotypically distinct subsets: one population that we have termed nN1 is CD11bint Ly6Gint, while the other two subsets are both CD11bhi Ly6Ghi and distinguishable by the absence (nN2) or presence (nN3) of CD11c and SiglecF. nN1 EVN originate in bone marrow (BM) within osseous structures in the skull. These locally produced neutrophils appear to access the adjacent NM via conduits that connect BM cavities to the submucosal lamina propria. nN2 cells reach the NM via the blood and readily engulf infectious microbes. In the absence of infection, nN2 cells differentiate into the nN3 subset, which does not capture microbes but assumes phenotypic and functional features of antigen-presenting cells, including the capacity to cross-present exogenous antigens to CD8 T cells. These findings indicate that steady-state mammalian NM harbors a unique innate cellular immune environment that is unlike any other barrier tissue.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Science Immunology
81 papers in training set
Top 0.1%
23.0%
2
Journal of Experimental Medicine
106 papers in training set
Top 0.2%
7.3%
3
Cell Reports
1338 papers in training set
Top 6%
7.0%
4
The Journal of Immunology
146 papers in training set
Top 0.2%
7.0%
5
Cell Host & Microbe
113 papers in training set
Top 0.8%
6.5%
50% of probability mass above
6
eLife
5422 papers in training set
Top 19%
4.4%
7
Immunity
58 papers in training set
Top 1%
4.0%
8
Cell
370 papers in training set
Top 5%
4.0%
9
PLOS Biology
408 papers in training set
Top 4%
3.1%
10
Nature Communications
4913 papers in training set
Top 43%
2.9%
11
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 25%
2.7%
12
Science Advances
1098 papers in training set
Top 11%
2.4%
13
Mucosal Immunology
42 papers in training set
Top 0.1%
2.1%
14
PLOS Pathogens
721 papers in training set
Top 5%
2.1%
15
JCI Insight
241 papers in training set
Top 3%
1.7%
16
Frontiers in Immunology
586 papers in training set
Top 4%
1.7%
17
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.7%
18
mBio
750 papers in training set
Top 8%
1.5%
19
Science
429 papers in training set
Top 16%
1.3%
20
Journal of Leukocyte Biology
40 papers in training set
Top 0.3%
1.0%
21
Nature
575 papers in training set
Top 13%
1.0%
22
Nature Immunology
71 papers in training set
Top 2%
1.0%
23
iScience
1063 papers in training set
Top 31%
0.8%
24
PLOS ONE
4510 papers in training set
Top 68%
0.7%
25
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.8%
0.7%
26
Science Translational Medicine
111 papers in training set
Top 7%
0.7%
27
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 0.9%
0.7%
28
EMBO reports
136 papers in training set
Top 8%
0.5%